Algert Global’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Sell
20,416
-9,050
-31% -$928K 0.02% 836
2026
Q1
$3.22M Sell
29,466
-29,880
-50% -$2.85M 0.05% 573
2025
Q4
$4.81M Sell
59,346
-6,922
-10% -$596K 0.08% 449
2025
Q3
$5.8M Buy
66,268
+51,744
+356% +$4.62M 0.1% 371
2025
Q2
$1.21M Buy
14,524
+7,070
+95% +$591K 0.03% 764
2025
Q1
$625K Buy
7,454
+3,930
+112% +$366K 0.02% 861
2024
Q4
$325K Sell
3,524
-509
-13% -$48.9K 0.01% 979
2024
Q3
$375K Sell
4,033
-31,384
-89% -$2.72M 0.01% 956
2024
Q2
$2.91M Sell
35,417
-7,189
-17% -$528K 0.1% 340
2024
Q1
$2.83M Sell
42,606
-10,024
-19% -$619K 0.11% 306
2023
Q4
$2.99M Buy
52,630
+1,680
+3% +$88K 0.12% 285
2023
Q3
$2.78M Buy
50,950
+45,400
+818% +$2.69M 0.13% 262
2023
Q2
$373K Buy
+5,550
New +$339K 0.02% 868
2022
Q2
Sell
-7,645
Closed -$355K 1309
2022
Q1
$355K Buy
+7,645
New +$342K 0.02% 922
2020
Q1
Sell
-25,649
Closed -$922K 470
2019
Q4
$922K Sell
25,649
-9,933
-28% -$343K 0.28% 130
2019
Q3
$1.22M Buy
35,582
+18,603
+110% +$594K 0.45% 77
2019
Q2
$475K Buy
+16,979
New +$472K 0.18% 176
2018
Q4
Sell
-26,894
Closed -$1.04M 400
2018
Q3
$1.04M Sell
26,894
-3,315
-11% -$119K 0.22% 168
2018
Q2
$1.01M Sell
30,209
-56,466
-65% -$2.01M 0.21% 178
2018
Q1
$3.14M Sell
86,675
-183
-0.2% -$6.34K 0.61% 50
2017
Q4
$2.77M Buy
86,858
+1,673
+2% +$57.3K 0.65% 38
2017
Q3
$3.19M Sell
85,185
-20,137
-19% -$685K 0.73% 16
2017
Q2
$3.29M Buy
105,322
+43,260
+70% +$1.25M 0.92% 3
2017
Q1
$1.53M Buy
62,062
+30,062
+94% +$706K 0.41% 93
2016
Q4
$811K Buy
+32,000
New +$710K 0.23% 182

Other funds holding LMAT

Algert Global's LMAT Position: Q2 2026 in Review

Algert Global reduced its LeMaitre Vascular (LMAT) stake by 31% in Q2 2026, selling an estimated $928K and leaving 20,416 shares worth $1.96M. The position accounts for 0.02% of the portfolio, ranked #836.

Algert Global first reported a position in LMAT in Q4 2016 and has held it in 25 quarters since. The position peaked at $5.8M in Q3 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Algert Global held 20,416 shares of LeMaitre Vascular worth $1.96M as of Q2 2026.
  • Algert Global sold 9,050 LeMaitre Vascular shares in Q2 2026, an estimated $928K.
  • LeMaitre Vascular made up 0.02% of Algert Global's portfolio in Q2 2026, its #836 holding.
  • Algert Global first reported a position in LeMaitre Vascular in Q4 2016 and has held it in 25 quarters since.
  • Algert Global's LeMaitre Vascular position peaked at $5.8M in Q3 2025.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.